Larimar Therapeutics (LRMR) Profit After Tax: 2014-2020
Historic Profit After Tax for Larimar Therapeutics (LRMR) over the last 6 years, with Mar 2020 value amounting to -$3.6 million.
- Larimar Therapeutics' Profit After Tax rose 72.56% to -$3.6 million in Q1 2020 from the same period last year, while for Mar 2020 it was -$35.9 million, marking a year-over-year increase of 38.67%. This contributed to the annual value of -$45.4 million for FY2019, which is 26.01% up from last year.
- Larimar Therapeutics' Profit After Tax amounted to -$3.6 million in Q1 2020, which was up 50.38% from -$7.3 million recorded in Q4 2019.
- Over the past 5 years, Larimar Therapeutics' Profit After Tax peaked at -$3.6 million during Q1 2020, and registered a low of -$17.7 million during Q1 2016.
- Moreover, its 3-year median value for Profit After Tax was -$13.1 million (2019), whereas its average is -$12.3 million.
- Its Profit After Tax has fluctuated over the past 5 years, first tumbled by 31.65% in 2016, then soared by 72.56% in 2020.
- Larimar Therapeutics' Profit After Tax (Quarterly) stood at -$10.4 million in 2016, then declined by 25.35% to -$13.1 million in 2017, then dropped by 11.35% to -$14.6 million in 2018, then skyrocketed by 50.23% to -$7.3 million in 2019, then spiked by 72.56% to -$3.6 million in 2020.
- Its Profit After Tax was -$3.6 million in Q1 2020, compared to -$7.3 million in Q4 2019 and -$12.9 million in Q3 2019.